CUPID2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member CUPID2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentRevenue01Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentRevenue02Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentRevenue03Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentRevenue01Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentRevenue02Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentRevenue03Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentResults01Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentResults02Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentResults03Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentResults01Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentResults02Member CUPID2021-10-012021-12-31in-bse-fin:FourReportableSegmentResults03Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentAssets01Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentAssets02Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentAssets03Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CUPID2021-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CUPID2021-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CUPID2021-10-012021-12-31in-bse-fin:OneReportableSegmentLiabilities03Member CUPID2021-12-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares CUPID 2021-04-01 2022-03-31 2022-02-07 INR Lakhs Third quarter Multi segment 2021-10-01 2021-12-31 Unaudited Consolidated 362232000.00 7582000.00 369814000.00 148858000.00 0.00 45980000.00 26261000.00 359000.00 6221000.00 105176000.00 332855000.00 36959000.00 0.00 36959000.00 10192000.00 1828000.00 12020000.00 0.00 24939000.00 0.00 0.00 0.00 -1328000.00 23611000.00 0.00 23611000.00 0.00 0.00 133380000.00 10 1.77 1.77 0.00 0.00 1.77 1.77 0.00 0.00 0.00 1 The above unaudited consolidated financial results were reviewed by the Audit Committee and have been approved by the Board of Director at its meeting held on 14th February 2022. 2. Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principle of lnd AS notified under the Companies (Indian Accounting Standard) Rules 2015 as amended from time to time. 3. The company’s business operation comprises of operating segments viz. Male and Female contraceptives, other relevant products and In Vitro Devices (IVD). 4. The Consolidated financial have been prepared in accordance with lnd AS 110 read with lnd AS 28 which include the standalone results of the parent company and its associate viz. Seloi Healthcare Private Limited. 5.The Board of Directors authorised Mr. Pradeep Kumar Jain Independent director to sign the consolidated financial results of the company for quarter ended 31st December, 2021. 6.The previous period / year financial figures have been regrouped rearranged wherever necessary to make them comparable. 7. The results of the Company are available for investors at https://www.cupidlimited.com/, https://www.nseindia.com/ and https://www.bseindia.com/ Place: Mumbai For and on behalf of Cupid Limited Date: 14th February, 2022 Pradeep Kumar Jain (Independent Director) Multi segment 2021-04-01 2021-12-31 Unaudited Consolidated 1013704000.00 32507000.00 1046211000.00 442437000.00 0.00 23174000.00 84371000.00 966000.00 18406000.00 299309000.00 868663000.00 177548000.00 0.00 177548000.00 43213000.00 3426000.00 46639000.00 0.00 130909000.00 0.00 0.00 0.00 -3830000.00 127079000.00 -611000.00 126468000.00 0.00 0.00 133380000.00 10 9.53 9.53 0.00 0.00 9.53 9.53 0.00 0.00 0.00 Other Expenses 105176000.00 Other Expenses 299309000.00 In Vitro Devices (IVD) 0.00 Male and Female Contraceptives & Jelly 362232000.00 Others / Unallocated 7582000.00 In Vitro Devices (IVD) 37216000.00 Male and Female Contraceptives & Jelly 976488000.00 Others / Unallocated 32507000.00 369814000.00 1046211000.00 369814000.00 1046211000.00 In Vitro Devices (IVD) -1449000.00 Male and Female Contraceptives & Jelly 29498000.00 Others / Unallocated 7582000.00 In Vitro Devices (IVD) 5145000.00 Male and Female Contraceptives & Jelly 136066000.00 Others / Unallocated 32507000.00 35631000.00 173718000.00 35631000.00 173718000.00 In Vitro Devices (IVD) 56052000.00 Male and Female Contraceptives & Jelly 776644000.00 Others / Unallocated 748993000.00 1581689000.00 In Vitro Devices (IVD) 3879000.00 Male and Female Contraceptives & Jelly 151001000.00 Others / Unallocated 53919000.00 208799000.00